Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review

Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) accounts for approximately 80% of all lung cancers, and most NSCLC is diagnosed in the advanced stage. The advent of immune check point inhibitors (ICIs) changed the therapeutic scenario both in m...

Descripción completa

Detalles Bibliográficos
Autores principales: Montrone, Michele, Rosati, Gerardo, Longo, Vito, Catino, Annamaria, Massafra, Raffaella, Nardone, Annalisa, Pesola, Francesco, Montagna, Elisabetta Sara, Marech, Ilaria, Pizzutilo, Pamela, Galetta, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003062/
https://www.ncbi.nlm.nih.gov/pubmed/36902620
http://dx.doi.org/10.3390/jcm12051833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003062/
https://www.ncbi.nlm.nih.gov/pubmed/36902620
http://dx.doi.org/10.3390/jcm12051833

Ejemplares similares